Comparison of prognoses according to non‐positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.
Anticancer drug sensitivity affects prognosis in ovarian carcinoma. Previously, we purified spectrin αII and βII tetramers from cisplatin‐resistant ovarian serous adenocarcinoma cells and demonstrated that they contribute to platinum anticancer drug resistance. In this clinical study, we focused on...
Main Authors: | Maeda, Osamu, Miyata‐Takata, Tomoko, Shibata, Kiyosumi, Kajiyama, Hiroaki, Mizuno, Mika, Tamakoshi, Koji, Shimoyama, Yoshie, Nakamura, Shigeo, Kikkawa, Fumitaka |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924366/ |
Similar Items
-
Growing Teratoma Syndrome of the Ovary Showing Three Patterns of Metastasis: A Case Report
by: Shibata, Kiyosumi, et al.
Published: (2013) -
Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women
by: Yoshikawa, Nobuhisa, et al.
Published: (2014) -
Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
by: Tsukamoto, Hirohisa, et al.
Published: (2008) -
P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling
by: Shibata, Kiyosumi, et al.
Published: (2007) -
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
by: Terauchi, Mikio, et al.
Published: (2007)